Adaptive T cell immune responses and atherogenesis - PubMed
Review
. 2010 Apr;10(2):197-202.
doi: 10.1016/j.coph.2010.02.003. Epub 2010 Mar 5.
Affiliations
- PMID: 20207195
- DOI: 10.1016/j.coph.2010.02.003
Review
Adaptive T cell immune responses and atherogenesis
Soraya Taleb et al. Curr Opin Pharmacol. 2010 Apr.
Abstract
Atherosclerosis is a chronic inflammatory disease of the arterial wall where both innate and adaptive immune responses contribute to disease initiation and progression. Initial studies have focused on the role of T helper-1 (Th1) and Th2 responses in atherosclerosis, and more recently evidence has been published supporting a protective role of regulatory T cells in this disease. A third member of the T helper set, IL-17-producing T cells, now called Th17 cells, was recently described as a distinct lineage that play important role in autoimmune diseases. Here, we review the current knowledge on the role of effector and regulatory T cell responses in atherosclerosis and discuss the contribution of the Th17 to this disease.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Regulatory T-cell immunity and its relevance to atherosclerosis.
Taleb S, Tedgui A, Mallat Z. Taleb S, et al. J Intern Med. 2008 May;263(5):489-99. doi: 10.1111/j.1365-2796.2008.01944.x. J Intern Med. 2008. PMID: 18410592 Review.
-
Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
George J. George J. Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):531-40. doi: 10.1038/ncpcardio1279. Epub 2008 Jul 8. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18607396 Review.
-
Targeting the development and effector functions of TH17 cells.
Ghilardi N, Ouyang W. Ghilardi N, et al. Semin Immunol. 2007 Dec;19(6):383-93. doi: 10.1016/j.smim.2007.10.016. Epub 2008 Jan 14. Semin Immunol. 2007. PMID: 18083530 Review.
-
Th17 cell induction and immune regulatory effects.
Bi Y, Liu G, Yang R. Bi Y, et al. J Cell Physiol. 2007 May;211(2):273-8. doi: 10.1002/jcp.20973. J Cell Physiol. 2007. PMID: 17311299 Review.
-
Adaptive immunity and atherosclerosis.
Andersson J, Libby P, Hansson GK. Andersson J, et al. Clin Immunol. 2010 Jan;134(1):33-46. doi: 10.1016/j.clim.2009.07.002. Epub 2009 Jul 26. Clin Immunol. 2010. PMID: 19635683 Review.
Cited by
-
Madhur MS, Funt SA, Li L, Vinh A, Chen W, Lob HE, Iwakura Y, Blinder Y, Rahman A, Quyyumi AA, Harrison DG. Madhur MS, et al. Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1565-72. doi: 10.1161/ATVBAHA.111.227629. Epub 2011 Apr 7. Arterioscler Thromb Vasc Biol. 2011. PMID: 21474820 Free PMC article.
-
Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis.
Gaddis DE, Padgett LE, Wu R, Nguyen A, McSkimming C, Dinh HQ, Araujo DJ, Taylor AM, McNamara CA, Hedrick CC. Gaddis DE, et al. Arterioscler Thromb Vasc Biol. 2021 Sep;41(9):2387-2398. doi: 10.1161/ATVBAHA.120.314189. Epub 2021 Jul 29. Arterioscler Thromb Vasc Biol. 2021. PMID: 34320835 Free PMC article.
-
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis.
Li B, Li W, Li X, Zhou H. Li B, et al. Curr Pharm Des. 2017;23(8):1216-1227. doi: 10.2174/1381612822666161230142931. Curr Pharm Des. 2017. PMID: 28034355 Free PMC article. Review.
-
Ex vivo culture of human atherosclerotic plaques: A model to study immune cells in atherogenesis.
Lebedeva A, Vorobyeva D, Vagida M, Ivanova O, Felker E, Fitzgerald W, Danilova N, Gontarenko V, Shpektor A, Vasilieva E, Margolis L. Lebedeva A, et al. Atherosclerosis. 2017 Dec;267:90-98. doi: 10.1016/j.atherosclerosis.2017.10.003. Epub 2017 Oct 7. Atherosclerosis. 2017. PMID: 29101840 Free PMC article.
-
Shi L, Ji Q, Liu L, Shi Y, Lu Z, Ye J, Zeng T, Xue Y, Yang Z, Liu Y, Lu J, Huang X, Qin Q, Li T, Lin YZ. Shi L, et al. J Cell Mol Med. 2020 Mar;24(5):3064-3078. doi: 10.1111/jcmm.14967. Epub 2020 Feb 5. J Cell Mol Med. 2020. PMID: 32022386 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical